You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

15 search results for: biomarkers

The Role of <b>Biomarkers</b> in Clinical Decision-Making in Atopic Dermatitis
expert video

The Role of Biomarkers in Clinical Decision-Making in Atopic Dermatitis

Dermatology
Dr. Stephan Weidinger talks about the role of biomarkers and their impact on clinical decision-making.
View more
ADVENT On Air | Early Intervention and Disease Modification in Atopic Dermatitis
Podcast

ADVENT On Air | Early Intervention and Disease Modification in Atopic Dermatitis

Dermatology
Prof. Thomas Bieber explores early intervention and disease modification in atopic dermatitis.
View more
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
Latest Real-World Data on Advanced Systemic Treatments for Patients With AD
expert video

Latest Real-World Data on Advanced Systemic Treatments for Patients With AD

Dermatology
This video from the September 2024 ADVENT symposium at EADV’s Annual Meeting in Amsterdam, the Netherlands, features Dr. Marjolein de-Bruin Weller discussing the latest real-world data on the effects of advanced systemic treatments on multiple outcomes including disease activity, patient-reported outcomes, biomarkers, and atopic comorbidities in patients with AD.
View more
CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis
Infographic

CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis

Dermatology
An infographic to explore the the key roles of CCL17 (TARC) in atopic dermatitis.
View more
FeNO as a Biomarker for Type 2 Asthma
expert video

FeNO as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Eugene Bleecker presents the utility of FeNO as a biomarker of type 2 inflammation, and its role in the disease burden of asthma.
View more
IgE as a Biomarker for Type 2 Asthma
expert video

IgE as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Jonathan Corren describes the diagnostic, predictive, and prognostic role of IgE as a biomarker of type 2 inflammation in asthma.
View more
Eosinophils as a Biomarker for Type 2 Asthma
expert video

Eosinophils as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Elliot Israel presents the utility of eosinophils as a biomarker of type 2 inflammation and their role in the disease burden of asthma.
View more
How Can FeNO Support the Management of Pediatric Asthma?
expert video

How Can FeNO Support the Management of Pediatric Asthma?

Pulmonology
Dr. Michael Blaiss discusses the importance of measuring FeNO in pediatric asthma patients.
View more
New Perspectives on Disease Modification in Atopic Dermatitis - Panel Discussion
expert video

New Perspectives on Disease Modification in Atopic Dermatitis - Panel Discussion

Dermatology
Panel discussion exploring what disease modification could involve in atopic dermatitis.
View more
New Perspectives on Disease Modification in Atopic Dermatitis
expert video

New Perspectives on Disease Modification in Atopic Dermatitis

Dermatology
An exploration into the concept and potential of disease modification through therapeutic interventions in AD.
View more
Exploring The Concept of Disease Modification in Atopic Dermatitis
expert video

Exploring The Concept of Disease Modification in Atopic Dermatitis

Dermatology
Exploring the concept ​of disease modification and related pathomechanisms ​in atopic dermatitis​.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: GreeceChange country/region